Features of cognitive impairment in chronic brain ischemia

Majidova, Y, Azimova, N, Narzieva, G, Bakhramov, M, Tajiev, T, Маджидова, Ё, Азимова , Н, Нарзиева , Г, Бахрамов , М, Таджиев , Т, Маджидова, Ё, Азимова , Н, Нарзиева , Г, Бахрамов , М, Таджиев , Т

Nevrologiya · 2023-yil

Annotatsiya

The article highlights the assessment of cognitive impairment in chronic cerebral ischemia and the treatment of these disorders. A study of the cognitive sphere of 40 patients with chronic cerebral ischemia (CHCI) of stage 1-2 was carried out. It was found that active systematic metabolic therapy in patients with Mexidol ® can reduce the severity of cognitive impairment, anxiety and depression.

Maqola ma’lumotlari
MualliflarMajidova, Y, Azimova, N, Narzieva, G, Bakhramov, M, Tajiev, T, Маджидова, Ё, Азимова , Н, Нарзиева , Г, Бахрамов , М, Таджиев , Т, Маджидова, Ё, Азимова , Н, Нарзиева , Г, Бахрамов , М, Таджиев , Т
JurnalNevrologiya
Nashr sanasi2023-04-26
Jild1
Son1
Betlar24-27
TilRus

Kalit so‘zlar

хроническая ишемия мозга, мексидол®, депрессия, сурункали мия ишемияси, Мехидол®, депрессия, chronic brain ischemia, Mexidol®, depression

Ilmiy soha

Nevrologiya jurnalidan boshqa maqolalar

Nevrologiya — barcha maqolalar